Pfizer Issues 2021 RFP for Growth Hormone Research

Pharmaceutical giant Pfizer has issued its 2021 RFP for Growth Hormone Research.

Through the RFP, grants of up to $100,000 will be awarded in support of research with potential to advance the medical knowledge of short stature. Projects submitted may focus on diagnostics, early treatment, new treatment paradigms, clinical outcomes, quality of life and patient-reported outcomes, medication adherence research, and translational or clinical research.

To be eligible, applicants must be based in the United States and have a medical or postdoctoral degree (MD, PhD, or equivalent), advanced nursing degree (BSN with a MS/PhD), or a degree in pharmacy, physiotherapy, or social work.

See the Pfizer website for complete program guidelines and application instructions.